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Abstract
Background: Patients suffering from diabetes show defective bacterial clearance. This study investigates the effects of
elevated plasma glucose levels during diabetes on leukocyte recruitment and function in established models of
inflammation.
Methodology/Principal Findings: Diabetes was induced in C57Bl/6 mice by intravenous alloxan (causing severe
hyperglycemia), or by high fat diet (moderate hyperglycemia). Leukocyte recruitment was studied in anaesthetized mice
using intravital microscopy of exposed cremaster muscles, where numbers of rolling, adherent and emigrated leukocytes
were quantified before and during exposure to the inflammatory chemokine MIP-2 (0.5 nM). During basal conditions, prior
to addition of chemokine, the adherent and emigrated leukocytes were increased in both alloxan- (62618% and 85621%,
respectively) and high fat diet-induced (77625% and 86617%, respectively) diabetes compared to control mice. MIP-2
induced leukocyte emigration in all groups, albeit significantly more cells emigrated in alloxan-treated mice (15.361.0)
compared to control (8.061.1) mice. Bacterial clearance was followed for 10 days after subcutaneous injection of
bioluminescent S. aureus using non-invasive IVIS imaging, and the inflammatory response was assessed by
Myeloperoxidase-ELISA and confocal imaging. The phagocytic ability of leukocytes was assessed using LPS-coated
fluorescent beads and flow cytometry. Despite efficient leukocyte recruitment, alloxan-treated mice demonstrated an
impaired ability to clear bacterial infection, which we found correlated to a 50% decreased phagocytic ability of leukocytes
in diabetic mice.
Conclusions/Significance: These results indicate that reduced ability to clear bacterial infections observed during
experimentally induced diabetes is not due to reduced leukocyte recruitment since sustained hyperglycemia results in
increased levels of adherent and emigrated leukocytes in mouse models of type 1 and type 2 diabetes. Instead, decreased
phagocytic ability observed for leukocytes isolated from diabetic mice might account for the impaired bacterial clearance.
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Introduction
Type 1 and type 2 diabetes (T1D and T2D), characterized by
long-term hyperglycemia when untreated, are both inflammatory
conditions. Islet inflammation promotes b-cell destruction in T1D
as well as in T2D, and systemic inflammation is involved in
development of insulin resistance in T2D. Endothelial dysfunction
due to prolonged hyperglycemia is commonly seen in diabetic
patients and results in micro- as well as macro-vascular and
neurologic complications [1,2,3]. The severity of complications
correlates with regulation of plasma glucose levels, i.e. to what
extent the deranged metabolism is normalized [1].
Type 2 diabetes and obesity are associated with low-grade
inflammation, which is particularly pronounced in visceral adipose
tissue. This inflammation is believed to contribute to insulin
resistance not only in the adipose tissue [4] but also in liver and
skeletal muscle [5], and thereby aggravates the diabetic state.
Despite the activated immune system, difficulties in clearing
bacterial infections are commonly seen in patients suffering from
diabetes [6,7]. Impaired bacterial clearance is prominent during
later stages of the disease and is most likely influenced by impaired
peripheral blood circulation, which attenuates recruitment of
leukocytes from the circulation to the infection site [8,9]. To what
extent hyperglycemia per se has direct effects on leukocyte
recruitment and function is not fully established.
To initiate an inflammatory response to a bacterial infection,
leukocytes have to migrate from the blood into the affected tissue.
This process occurs in consecutive steps depicted in the leukocyte
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released from activated macrophages (e.g. Macrophage Inflam-
matory Protein 2, MIP-2) are sequestered apically on nearby
venular endothelial cells, and activate rolling leukocytes to
upregulate integrins. This results in firm adhesion of leukocytes
to the endothelium, followed by crawling to optimal sites for
emigration and ultimately transmigration through the vessel wall
[10,11,12,13]. Extravasated leukocytes then chemotax towards the
site of infection, where bacteria are killed by phagocytosis and
reactive oxygen species generation [14]. Endothelial dysfunction
caused by hyperglycemia is believed to contribute to development
of secondary complications to diabetes, which might involve
increased leukocyte-endothelial interactions and leukocyte recruit-
ment. However, contradictory results of leukocyte-endothelial cell
interactions during inflammation in diabetes models have been
revealed, as either decreased [15,16,17] or increased [18] events
are reported, as well as elevated levels of adhesion molecules [19].
By using two different mouse models of diabetes resulting in
moderate and severe increased plasma glucose levels respectively,
the present study investigates the role of hyperglycemia on
leukocyte recruitment and function in an acute model of
inflammation, in addition to a clinically relevant model of
bacterial infection.
Results
Alloxan pre-treatment and high fat diet caused severely
and moderately increased plasma glucose
concentrations, respectively
Two different models of diabetes were used: one with similarities
to T1D (alloxan-treatment) in which mice were severely hypergly-
cemic (Table 1) and insulin deficient, whereas T2D was induced by
HFD which resulted in moderate hyperglycemia (Table 1) with
increased serum insulin concentrations. All mice gained weight with
time, but mice given a HFD had significantly higher body weights
after 5 weeks on diet and onwards (Figure 1A). HFD also
increased plasma glucose concentrations, resulting in significantly
increased levels from 9 weeks and onwards compared to mice on
control diet (Figure 1B). While serum insulin levels were
undetectable in alloxan-treated mice (data not shown), HFD
mice had greatly increased serum insulin levels when measured
after 15 weeks of HFD (58619 ng/ml) compared to controls
(1.560.8 ng/ml, figure 1C). Glucose tolerance was impaired in
the moderately hyperglycemic HFD mice after 15 weeks of HFD
(Figure 1D).
Unstimulated leukocyte recruitment was increased in
both alloxan- and diet-induced diabetes
Leukocyte recruitment was studied using intravital microscopy
of the cremaster muscle in severely hyperglycemic alloxan-treated
mice (3 days after alloxan injection), mice on HFD (moderate
hyperglycemia) and normoglycemic untreated mice (Table 1). At
basal conditions, prior addition of the inflammatory chemokine
MIP-2 to the superfusate, increased numbers of adherent and
emigrated leukocytes were detected in both alloxan- and HFD-
treated groups compared to control mice (Figure 2A–B). No
differences in number of rolling leukocytes or their rolling velocity
between these groups could be detected (Table 1).
To investigate if increased basal leukocyte recruitment in
diabetic mice could be induced by acute elevation of plasma
glucose concentration, a group of normoglycemic mice were
pretreated with D-mannuheptulose intraperitoneally. This treat-
ment inhibits glucose oxidation and, together with a glucose
injection i.v., resulted in prolonged hyperglycemia with plasma
glucose levels of 17.361.8 mmol/l approximately 2 h post
administration. However, this acute induction of hyperglycemia
did not increase the number of adherent or emigrated leukocytes
compared to what was observed in untreated mice (Figure 2A–B).
These results indicate a low grade activation of the immune
system and/or endothelium in mouse models of diabetes, resulting
in increased number of adherent leukocytes to the postcapillary
venules and ultimately increased leukocyte recruitment to tissue
which is not attributable to acute increases in blood glucose levels.
Table 1. Plasma glucose levels, leukocyte rolling flux and rolling velocity in control and diabetic mice.
Plasma glucose levels (mmol/l)
Control Alloxan High fat diet
8.560.5 .27.8 11.461.4
Rolling Flux (cells/min)
Time (min) Control Alloxan High fat diet
0 35.364.4 52.866.2 49.366.4
30 23.962.9 30.862.7 29.563.0
60 18.261.7 23.063.3 23.164.6
90 13.962.3 17.863.1 22.266.0
Rolling Velocity (mm/s)
Time (min) Control Alloxan High fat diet
0 36.968.9 30.663.6 25.566.5
30 37.968.4 37.264.4 32.469.4
60 35.766.6 36.565.8 29.768.5
90 33.966.5 31.763.3 30.468.7
Plasma glucose levels at the time of experiment, number of rolling leukocytes in the cremaster muscle per minute (Rolling flux), and the rolling velocity of the first 10
rolling leukocytes at basal level (time 0) and after 30, 60 and 90 min of MIP-2 superfusion in control (n=6), alloxan- (n=6) and diet-induced diabetic (n=5) mice.
doi:10.1371/journal.pone.0022480.t001
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response to MIP-2 was observed in sustained
hyperglycemic mice
To investigate the role of hyperglycemia for leukocyte
recruitment during inflammation, the chemokine MIP-2 was
added to the superfusate of the cremaster preparation. This
chemokine is known to recruit predominantly neutrophils but also
some monocytes (88% versus 12% respectively) [13]. The number
of rolling leukocytes decreased with time of MIP-2 superfusion to
similar levels in all groups, while rolling cell velocities were not
affected (Table 1), as shown previously in MIP-2 treated C57Bl/6
mice [13]. The difference in number of adherent leukocytes
between normo- and hyperglycemic mice seen under basal
conditions disappeared after MIP-2 addition as the number of
adherent leukocytes increased to similar levels (Figure 2A). MIP-2
caused an increase of the number of emigrated cells with time in
the normoglycemic mice (Figure 2B), which was also seen in both
models of diabetes, but occurred at different times as the number
of emigrated leukocytes in the alloxan-diabetic mice increased
already after 30 min (as in normoglycemic mice), whereas the
number of emigrated leukocytes in the HFD-treated mice
increased only after 90 minutes of MIP-2 superfusion (Figure 2B).
At the latter time point, significantly more recruited leukocytes
were observed in the hyperglycemic mice compared to the
normoglycemic individuals (Figure 2B), even though it did not
reach significance in the diet induced model (p=0.061). This
indicates that leukocytes are more efficient in emigrating out of the
inflamed blood vessel in the diabetic mice compared to control
mice since similar levels of adherent leukocytes were observed in
all groups. MIP-2 had similar effects on adherent and emigrated
cells in acute hyperglycemia (D-mannuheptulose-treated) as in
control mice indicating that acute hyperglycemia does not increase
leukocyte recruitment during inflammation.
The differential count is unchanged by alloxan treatment
To exclude the possibility that the observed increased leukocyte
recruitment in diabetic mice was caused by change of the total
number and/or proportion of immune cells in the alloxan-treated
hyperglycemic model, total white blood cells and a differential
count was performed. No significant differences could be detected
Figure 1. Increased weight, blood glucose and insulin, and impaired glucose tolerance in high fat diet (HFD) mice. A, Weight gain in
control mice (white, n=7) and mice fed a HFD (black, n=5) and B, plasma glucose concentrations in mice on control (white) or high fat diet (black)
over time. C, Serum insulin concentrations in mice after 15 weeks of control or high fat diet. D, Glucose tolerance test in control or high fat fed mice
presented as area under curve (AUC) of plasma glucose levels6time, 15 weeks after diet start. *p,0.05. Data are means 6 SEM.
doi:10.1371/journal.pone.0022480.g001
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9/l and 3.160.5610
9/l),
lymphocytes (8462% and 7565%), monocytes (961% and
1363%) or granulocytes (761% and 1263%) between the control
(n=4) and alloxan-treated (n=3) mice, respectively.
Faster initial reduction in bacterial number but impaired
long-term bacterial clearance in alloxan-induced diabetic
mice
To investigate if the observed increase in leukocyte recruitment
could be transferred into a clinically relevant model of bacterial
infection, normo- and hyperglycemic mice were challenged by
subcutaneous Staphylococcus aureus (xen29, producing luciferase).
Since most profound changes on leukocyte recruitment was found
in the severely hyperglycemic model (alloxan-induced), this model
waschosenforevaluationofbacterial clearance.Thehyperglycemic
mice showed decreased ability to clear the bacterial infection
(Figure 3A–B) and only 12% of the alloxan-treated mice were
cleared after ten days, while more than 50% of control mice were
free of infections (Figure 3A). Interestingly, total bioluminescence
decreased faster during the first week of infection in the alloxan-
treated compared to control mice (Figure 3C) but did not disappear
in any of the alloxan-treated mice during the first week (Figure 3A).
The subtypes of recruited leukocytes were evaluated 2 days after
bacterial infection when the inflammation was most prominent.
MPO contents revealed increased neutrophil recruitment to the
infected area in alloxan-treated mice, however not statistically
significant (p=0.063, Figure 4A), in agreement with Figure 2B.
Confocal visualization of bacteria infected regions of control and
alloxan-treated mice revealed presence of numerous macrophages
in both groups (Figure 4B). Macrophage populations were not
quantified since the exact location of the stained section in relation
to the infection,which most probably reflects on numberofimmune
cells, was difficult to appreciate.
Time with hyperglycemia might influence recruitment of
leukocytes as well as their function. The type 1 diabetic mice
exhibiting increased leukocyte recruitment (Figure 2) received
alloxan 3 days prior experiment. The diabetic mice challenged
with bacteria 3 days after alloxan treatment, were hyperglycemic
Figure 2. Increased leukocyte recruitment to MIP-2 in diabetic mice. The number of adherent (A) and emigrated cells (B) in the cremaster
muscle of control (white, n=6), alloxan-treated (dark grey, n=6), high fat diet-induced diabetic (light grey, n=5) and acute glucose-infused (black,
n=4) mice before (time 0) and after MIP-2 addition to the superfusate (0.5 nmol/L). *p,0.05 compared to other groups at the same time point.
{p,0.05 compared to time 0 in the same group. Data are means 6 SEM.
doi:10.1371/journal.pone.0022480.g002
Leukocyte Recruitment in Mouse Diabetic Models
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22480for the studied period of 13 days in total (Figure 3). To exclude
that the impaired bacterial clearance observed in diabetic mice
was not due to decreased leukocyte recruitment at later time
points, the cremaster muscle of mice hyperglycemic for 8 days was
superfused with MIP-2. However, no difference could be detected
in mice treated with alloxan three (n=6) or eight (n=7) days
earlier in terms of number of recruited neutrophils after 90 min of
MIP-2 superfusion: adherent cells (9.360.9 and 10.961.3),
emigrated cells (15.361.0 and 12.961.4), respectively.
Less phagocytic cells in alloxan-treated mice
Impaired leukocyte function could explain the contradictory
results of increased recruitment of leukocytes and defect
bacterial clearance observed in alloxan-diabetic mice. The
Figure 3. Impaired bacterial clearance in alloxan-induced diabetic mice. A, Clearance rate of bioluminescent Staphylococcus aureus
(1610
7 CFU/ml) in control (black, n=11) and alloxan-induced diabetic mice (grey, n=9) until 50% of the control mice were cleared (dashed line). B,
Representative images of bioluminescent S. aureus infected regions in control (upper panel) and alloxan-induced diabetic mice (lower panel) directly
post inoculation (I and IV), and 2 (II and V) and 10 days (III and VI) post inoculation. C, Total bioluminescence in control (black, n=11) and alloxan-
treated (white, n=9) mice over time. The dashed line represents average background bioluminescence. Data are means 6 SEM.
doi:10.1371/journal.pone.0022480.g003
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LPS-coated beads to mimic leukocyte activation in bacterial
infection [20]. Three hours following i.p injection of LPS-coated
beads, peritoneal leukocytes were isolated and analyzed for
fluorescence (as a measure of phagocytosis of beads) using flow
cytometry. While the populations of leukocytes with phagocytic
abilities (neutrophils and macrophages) were similar (2.160.5
10
5 and 2.460.3 10
5 cells/ml, respectively) in the peritoneal
lavages of alloxan-treated (3 days prior experiments, n=4) and
control (n=5) mice, the number of cells that contained LPS-
coated beads was decreased by 50% in the alloxan-treated mice
compared to control mice (Figure 5), demonstrating impaired
phagocytosis.
Discussion
The present study investigates a common complication to
diabetes, impaired bacterial clearance, using in vivo models of
longitudinal visualization of subcutaneous infection, leukocyte
recruitment in single venules and leukocyte phagocytic ability.
Increased leukocyte recruitment was observed during basal
conditions as well as during acute inflammation in mice with
alloxan- or diet-induced diabetes, i.e. animals with severe or
moderate hyperglycemia. To understand how this correlates to
difficulties in clearing bacterial infections, alloxan-induced diabetic
mice were challenged by Staphylococcus aureus. Interestingly, despite
increased numbers of recruited leukocytes, diabetic mice remained
infected for a longer time period compared to control mice, which
correlated to a 50% decreased phagocytic ability of diabetic
leukocytes.
Figure 4. Recruited neutrophils and macrophages to the bacterial infection in control and alloxan-induced diabetic mice.
Extravasated neutrophils expressed as concentration of myeloperoxidase (MPO) (A) in the bacteria-infected backs in control (n=7) and alloxan-
treated diabetic (n=7) mice. Data are means 6 SEM. B, Representative images of macrophages (Alexa555-konjugated F4/80 antibody) in bacteria-
infected area in control and alloxan-treated mice. Scale bar: 100 mm.
doi:10.1371/journal.pone.0022480.g004
Figure 5. Decreased phagocytic ability of leukocytes in
diabetic mice. Percentage of phagocytic leukocytes phagocytizing
LPS-coated fluorescent beads in the peritoneal cavity in control (n=5)
and alloxan-treated diabetic (n=4) mice. *p,0.05. Data are means 6
SEM.
doi:10.1371/journal.pone.0022480.g005
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immune responses to bacterial infections. This is believed to be
caused in part by impaired peripheral blood circulation which
develops with time of fluctuating and uncontrolled plasma glucose
levels [1]. The effect of hyperglycemia per se on leukocyte
recruitment toinflamedmusclewas inthepresentstudyinvestigated
by intravital microscopy of single venules. We found that during
basal conditions prior to addition of chemokines, an increased
number of leukocytes were recruited into muscle in long-term but
not acutely hyperglycemic mice. This might reflect that prolonged
hyperglycemia induces expression of adhesion molecules on muscle
venular endothelium and/or circulating leukocytes. Still more
leukocyteswererecruitedduringinflammation(MIP-2activation)in
the alloxan-induced, type 1 diabetes model, and a similar trend was
seen also in the type 2 diabetes model. However, no effects were
seen after an acutely induced hyperglycemia. Thus, our results show
that hyperglycemic mice with time develop a more activated
immune system during both non-inflammatory as well as
inflammatory conditions. These effects correlate with levels of
hyperglycemia, as they were more profound in the model of severe
hyperglycemia even though the absence of anti-inflammatory
insulin in the alloxan-treated model might contribute to this
observation. Our observations are in agreement with a study of
leukocyte-endothelial interactions in the mesentery during ische-
mia-reperfusion injury in streptozotocin-treated rats [18]. In this
study, ischemia-reperfusion caused increased leukocyte adhesion
and emigration to a greater extent in the diabetic rats compared to
control rats, even though no differences in the number of adherent
and emigrated leukocytes were seen under basal conditions prior
injury between groups. However, in another study of alloxan-
treated rats, a decrease in leukocyte-endothelial cell interactions in
the internal spermatic fascia after inflammatory challenge was
demonstrated [17]. An important discrepancy between the former
study in alloxan-treated rats and the present study in mice is the
time period of severe hyperglycemia, as longer hyperglycemic
periods correlate with higher degree of for instance protein
glycosylation that in turn might impair immune responses as well
as other body functions. In our study, mice had been hyperglycemic
(.27.8 mmol/l) for only 3–8 days prior the inflammatory
challenge, while the rats had been confirmed hyperglycemic
(.30 mmol/l) for 33 days after alloxan injection [17].
To expand our results of acute leukocyte recruitment, bacterial
clearance was studied in a clinically relevant infection model in
severely hyperglycemic mice, in which the leukocyte recruitment
effect was most prominent. We found that the alloxan-treated mice
showed decreased ability to totally clear the bacterial infection
compared to control mice, despite a greater initial decrease of
bacteria post-infection and increased number of recruited
neutrophils to the infected area (MPO, p=0.063). These results
are in line with clinical findings in diabetic patients, as bacterial
infections are abundantly occurring complications of the disease
[6,7], and are in accordance with a previous experimental study of
S. aureus injected in the hindpaw of non-obese diabetic mice
(NOD, an autoimmune mouse model of type 1 diabetes) [21].
However, NOD mice display numerous other immune abnormal-
ities such as autoimmune thyroiditis, autoimmune peripheral
polyneuropathy as well as systemic lupus erythematosus-like
disease [22] which most probably also affect inflammatory
responses needed for bacterial clearance, thus influencing the
results of this study. Impaired bacterial clearance in NOD mice
was attributed to decreased tissue levels of MIP-2 at the site of
infection, resulting in decreased leukocyte recruitment [21].
However, whether this defect in MIP-2 secretion is due to the
diabetic stage or the immune defect in NOD mice is uncertain.
The initial drop of bacterial luminescence observed in the
diabetic mice could reflect increased numbers of recruited
leukocytes, or an increased ability to initially kill inoculated
bacteria through secretion of higher levels of toxic oxygen radicals.
The latter has previously been reported in several studies.
Neutrophils from diabetic cats were observed to secrete more
toxic oxygen radicals when activated by phorbol myristate acetate
compared to neutrophils from healthy cats [23], and intraperito-
neal macrophages from alloxan-induced diabetic mice produced
increased levels of reactive oxygen intermediates [24]. Further, an
acute glucose challenge of healthy human subjects was shown to
induce reactive oxygen species generation in neutrophils [25], and
neutrophils isolated from patients with type 2 diabetes were found
to produce increased amounts of reactive oxygen species
compared to neutrophils from healthy controls [26]. These data
cannot explain the decreased ability to clear bacterial infections
shown clinically as well as in the present study. Instead, impaired
bacterial clearance might be due to impaired ability to ingest, kill
and remove bacteria and debris accumulated during infection.
Indeed, impaired leukocyte phagocytosis has been observed in
patients suffering from diabetes [27,28]. This defect was seen
already at moderately increased hyperglycemia (.11 mmol/l)
indicating that it appears in patients suffering from both
uncontrolled type 1 and type 2 diabetes. In the present study,
we developed a phagocytic assay where leukocytes were recruited
to the peritoneal cavity by injection of LPS-coated fluorescent
beads, and we could detect, by using flow cytometry, a 50%
decrease of leukocyte phagocytosis in alloxan-treated diabetic
mice. However, these experimental results need to be confirmed in
studies of leukocyte phagocytic abilities in diabetic patients
suffering from recurrent bacterial infections.
In conclusion, the results presented here suggest that the
reduced ability to clear bacterial infections during diabetes is not
due to impaired leukocyte recruitment as prolonged hyperglyce-
mia caused increased number of emigrated leukocytes in tissue
during basal conditions as well as during acute inflammation.
Despite the increased numbers of recruited leukocytes to
inflammation in the diabetic mice, the bacterial infection
remained for longer periods due to a defect leukocyte phagocy-
tosis.
Materials and Methods
Ethical statement
All experiments were approved by the Swedish Laboratory
Animal Committee in Uppsala, approval number C268/9 and
C180/10.
Animals
C57BL/6 male mice, (B&K Universal, Scanbur, Stockholm,
Sweden), were housed in animal facility under standardized
conditions (21–22uC, 12 h light/12 h darkness) with free access to
tap water and pelleted food (Type R36, Lantma ¨nnen, Kimstad,
Sweden) or high fat diet (HFD; 60% kcal from fat, D12492;
Research diets, New Brunswick, NJ, USA).
Induction of hyperglycemia
Acute hyperglycemia: Acute and prolonged hyperglycemia was
induced by intraperitoneal injection of D-Mannuheptulose (a
glucose oxidation inhibitor, 0.2 mg/kg body weight, Sigma-
Aldrich, St. Louis, MO, USA), before intravenous glucose
injection (0.6 g/kg b.w). Type 1 diabetes model: Hyperglycemia
(plasma glucose levels .27.8 mmol/l) was induced by a tail vein
injection of alloxan (75 mg/kg body weight, Sigma-Aldrich)
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experiment or inoculation of bacteria. Type 2 diabetes model:
Moderate hyperglycemia (plasma glucose levels ,11 mmol/l) was
induced by HFD for 15 weeks.
Plasma glucose and serum insulin concentrations
Plasma glucose levels were monitored in blood from the tail with
test reagent strips (detection range 1.1–27.8 mmol/l; Freestyle,
Abbott, Stockholm, Sweden) once a week (control and HFD mice)
and daily following alloxan administration. Serum insulin
concentrations were measured with insulin ELISA (detection limit
1.5 mg/l, Mercodia Rat Insulin ELISA; Mercodia AB, Uppsala,
Sweden) in mice after 15 weeks of HFD.
Glucose tolerance tests
Glucose tolerance test was performed after 15 weeks of HFD
and in aged-matched controls. Plasma glucose concentrations in
blood from the tail were measured with test reagent strips before
administering 2 g/kg body weight D-glucose (300 mg/ml; Frese-
nius Kabi, Uppsala, Sweden) intravenously into the tail. Plasma
glucose concentrations were thereafter measured at 10, 30, 60, and
120 min post-administration.
In vivo recruitment of leukocytes
Aged-matched mice were anaesthetized by spontaneous inhalation
of ,2.4% isoflurane (ForeneH, Abbott Scandinavia AB, Stockholm,
Sweden) in a mixture of air and oxygen (total oxygen 40%) through a
breathing mask connected to an isoflurane pump (Univentor 400
Anesthesia Unit, AgnTho’s AB, Lidingo ¨, Sweden). Plasma glucose
concentrations were measured before and after induction of
anesthesia, and the levels were not affected by isoflurane anesthesia.
The animals were placed on a water-heated operating table to
maintain body temperature at ,37uC. The depth of anesthesia was
controlled byregularly monitoring peripheral reflexes. The cremaster
muscle was prepared as previously described [31,32]. Briefly, the
muscle was dissected free and opened longitudinally with cautery. It
was held flat on cover slip by attaching five sutures in the corners and
was then constantly superfused (1 ml/min) with pre-warmed
bicarbonate buffered saline (pH 7.4), throughout the experiment.
After a 30-minute resting period, a cremasteric venule with a
diameter of ,25–35 mmwasselectedforblood flowrecording during
a 5-minute-period through an intravital microscope (Leica Micro-
systems DM5000B, Wetzlar, Germany) with a CCD camera
(Hamamatsu Orca-R2, Hamamatsu City, Japan) connected to a
computer with Volocity 5.0 Acquisition software. After the first
recording period, the chemokine MIP-2 (CXCL2; R&D Systems,
Abingdon, UK) was added to the superfusate throughout the
remaining experiment (0.5 nmol/l). MIP-2, the murine homologue
to IL-8, binds to the receptor CXCR2 and recruits predominantly
neutrophils [31]. Five minute periods were recorded at 30, 60 and
90 min after MIP-2 addition. The number of rolling leukocytes was
counted during each of these 5-minute-periods and average number
of rolling leukocytes per min was calculated. The rolling cell velocity
of the first ten rolling cellsduring each period was measured. Also, the
number of adherent leukocytes in a 100 mm long segment of the
venule, as well as the number of emigrated cells in the field of view
(200 mm6300 mm, 0.06 mm
2) was analyzed. The experiments were
ended by collecting blood through heart puncture for analysis of
serum insulin concentrations.
Differential counts
Blood from alloxan-treated and control mice were drawn via
heart puncture into Microtainer K2E tubes (BD Franklin Lakes,
USA) for white blood cell differential count using an ABX
MICROS 60 CS/CT, ABX Diagnostics (Montpellier, France).
Bacterial clearance imaging
The mice had their fur on their backs removed using shaver and
depilation cream (Veet, Reckitt Benckiser, Valora Trade, Stock-
holm, Sweden) 24 h prior to bacterial inoculation. Bioluminescent
Staphylococcus aureus (Xen29, Caliper life sciences; Alameda, USA)
cultured overnight in liquid medium (10 ml LB medium with
200 mg/ml kanamycin) was subcultured (1:10) until exponential
growth rate (approximately 1 h). The amount of bacteria was deter-
mined using spectrophotometry (OD600=0.5,1.4610
8 CFU/ml).
,1610
7 CFU were suspended in PBS solution containing
10 mg/ml of inert Cytodex beads (Sigma Aldrich). Approximately
,1610
6 CFU bacteria in 100 ml PBS solution were inoculated
subcutaneously in anaesthetized alloxan-treated (plasma glucose
.27.8 mmol/l) or normoglycemic mice. Bacterial infection was
monitored using a bioimaging device (IVIS Spectrum, Caliper Life
Sciences, Hopkinton, USA) in isoflurane anaesthetized mice at time
points 0, 2, 5, 12, and 24 h, and then every 24 h post inoculation for
10 days. Images were analyzed and bio-luminescence quantification
was done using Living Image 3.1 software (Caliper).
In vitro evaluation of inflammation
Some infected mice were sacrificed two days after subcutaneous
bacteria inoculation to evaluate type and amount of recruited
leukocytes. The center of infected backs was collected and tissue
samples (,20 mg) were homogenized in lysis buffer and analyzed
for Myeloperoxidase (MPO) content using mouse MPO ELISA
(Hycult biotech, Uden, Netherlands). The remaining tissue
samples were mounted in tissue tek (Cellab, Sollentuna, Sweden),
frozen in 270uC prior cryosectioning and staining of macrophage
content using anti-F4/80 antibody (conjugated with Alexa Fluor
555) and nuclei using Hoechst 33342 (Invitrogen, Stockholm,
Sweden) before confocal microscopy (Nikon C-1 with Plan Fluor
ELWD 206/0.45 objective) analysis.
Phagocytosis assay
Fluorescent beads (2 mm, Polyscience, Inc., Eppelheim, Ger-
many) coated with LPS (lipopolysaccharide, 100 mg/ml, Sigma-
Aldrich) at 4uC over night were injected intraperitoneally in mice
treated with alloxan 3 days earlier or control mice. Three hours
later, recruited phagocytic cells were isolated via peritoneal lavage
in isoflurane-anesthetized mice. Four ml of HBSS (Sigma-Aldrich)
were injected into the peritoneal cavity followed by a 5-minute
massage of the abdomen before the fluid was collected. Leukocytes
were isolated via Percoll gradient isolation consisting of Percoll
stock solution (9 ml of Percoll and 1 ml of 106PBS) diluted into
72%, 64%, and 52% in PBS [33]. The total populations of
phagocytic leukocytes as well as percentage of the population that
contained fluorescent beads were determined using flow cytometry
(FACScalibur, BD Biosciences). Data are presented as percentage
of phagocytic cells that contained beads.
Statistical analysis
All values are expressed as mean 6 SEM. One way repeated
measurements of ANOVA was used when comparing the same
animal at different time points with Dunnett’s post hoc test. To
compare groups at the same time point, one way ANOVA with
Fischer’s LSD post hoc test was used. Student’s t-test was used when
two groups were compared. Statistical significance was set to
P,0.05. All statistical analyses were carried out using SigmaStat 3.5
(Systat Software, Richmond, VA, USA) except the Kaplan-Meier
Leukocyte Recruitment in Mouse Diabetic Models
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Jolla, CA, USA).
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